A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96
β Scribed by Howard H. Bailey; Donna Levy; Linda S. Harris; Julian C. Schink; Francine Foss; Peter Beatty; Scott Wadler
- Book ID
- 112248919
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 39 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twentyβfive patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo
## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast
## Abstract ## BACKGROUND. There is a need to identify active new regimens in patients with advanced urothelial cancer. Pemetrexed and gemcitabine are active agents in advanced urothelial cancer. A phase 2 trial of the combination of these 2 agents was performed in patients with advanced urothelia